Patents by Inventor Rodney A. Beck

Rodney A. Beck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIPLEXED METHOD FOR DIAGNOSING CLASSICAL HODGKIN LYMPHOMA
    Publication number: 20150226743
    Abstract: A method of analyzing a biological sample suspected of having classic Hodgkin lymphoma, comprising (1) detecting, in a single sample, for the expression of at least two biomarkers selected from CD30, CD15, CD20, CD45, CD3, Pax-5, CD79A, BOB1 and OCT-2; and (b) analyzing the sample based on the presence, absence and/or expression level of the at least two biomarkers. Also provided is a method wherein all the nine biomarkers are analyzed on a single sample. Further provided are method for diagnosing classical Hodgkin lymphoma, as well as system and kit that comprise the means for executing the novel methods.
    Type: Application
    Filed: May 30, 2013
    Publication date: August 13, 2015
    Applicant: CLARIENT DIAGNOSTICS SERVICES, INC.
    Inventors: Lawrence M. Weiss, Rodney A. Beck, Lakshmi Sireesha Kaanumalle, Antti E. Seppo, David Lavan Henderson, Alex David Corwin, Kevin Bernard Kenny, Colin Craig Mcculloch, Fiona Ginty, Alexanderr G. Bordwell, Michael S. Lazare, Denise A. Hollman-Hewgley
  • TLE3 AS A MARKER FOR CHEMOTHERAPY
    Publication number: 20150198599
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 16, 2015
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • MULTIPLEXED ASSAY METHOD FOR LUNG CANCER CLASSIFICATION
    Publication number: 20150141278
    Abstract: A method for providing a composite image of a single biological sample from a patient suspected of having lung cancer, comprising the steps of generating a first image of the biological sample, generating a second image of the biological sample, and generating a composite image that provides the relative location of both the targeted proteins. Also provided is a method of analyzing a biological sample, comprising providing a composite image of the biological sample according to the method for providing a composite image, and analyzing the expression of the protein of interest from the composite image. Further provided are method for classification of lung cancer, as well as system and kit that comprise the means for executing the novel methods.
    Type: Application
    Filed: May 28, 2013
    Publication date: May 21, 2015
    Applicant: CLARIENT DIAGNOSTIC SERVICES, INC.
    Inventors: Denise A Hollman-Hewgley, Rodney A Beck, Brian Z Ring, Lakshmi Sireesha Kaanumalle
  • MULTIPLEXED DIAGNOSIS METHOD FOR CLASSICAL HODGKIN LYMPHOMA
    Publication number: 20150105283
    Abstract: A method for providing a composite image of a single biological sample from a patient suspected of having classical Hodgkin lymphoma, comprising the steps of generating a first image of the biological sample including the presence, absence and/or expression level of a first biomarker, generating a second image of the biological sample including the presence, absence and/or expression level of a second biomarker, and generating a composite image that provides the relative location or expression of both biomarkers. Also provided is a method of analyzing a biological sample, comprising providing a composite image of the biological sample according to the method for providing a composite image, and analyzing the expression of the biomarkers of interest from the composite image. Further provided are method for diagnosing classical Hodgkin lymphoma, as well as system and kit that comprise the means for executing the novel methods.
    Type: Application
    Filed: May 30, 2013
    Publication date: April 16, 2015
    Applicant: CLARIENT DIAGNOSTICS SERVICES, INC.
    Inventors: Lawrence M. Weiss, Rodney A. Beck, Lakshmi Sireesha Kaanumalle, Antti E. Seppo, David Lavan Henderson, Alex David Corwin, Kevin Bernard Kenny, Colin Craig McCulloch, Fiona Ginty, Alexanderr G. Bordwell, Michael S. Lazare, Denise A. Hollman-Hewgley
  • TLE3 as a marker for chemotherapy
    Patent number: 9005900
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: April 14, 2015
    Assignee: Clarient Diagnostic Services, Inc.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 as a marker for chemotherapy
    Patent number: 8785156
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: July 22, 2014
    Assignee: Clarient Diagnostic Services, Inc.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 AS A MARKER FOR CHEMOTHERAPY
    Publication number: 20110015259
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Application
    Filed: September 24, 2010
    Publication date: January 20, 2011
    Applicant: Applied Genomics, Inc.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 as a marker for chemotherapy
    Patent number: 7816084
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: October 19, 2010
    Assignee: Applied Genomics, Inc.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 as a marker for chemotherapy
    Patent number: 7754431
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: July 13, 2010
    Assignee: Applied Genomics, Inc.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 AS A MARKER FOR CHEMOTHERAPY
    Publication number: 20100062444
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Application
    Filed: October 13, 2009
    Publication date: March 11, 2010
    Applicant: APPLIED GENOMICS, INC.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck
  • TLE3 AS A MARKER FOR CHEMOTHERAPY
    Publication number: 20090155798
    Abstract: Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
    Type: Application
    Filed: November 25, 2008
    Publication date: June 18, 2009
    Applicant: APPLIED GENOMICS, INC.
    Inventors: Brian Z. Ring, Douglas T. Ross, Robert S. Seitz, Rodney A. Beck